Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02918942 · ClinicalTrials.gov registry record
Tympanoseal (Tympanic Membrane Device) Clinical Study
A clinical trial, sponsored by Grace Medical.
- Completed
- Registry status
- 25
- Enrollment target
NCT02918942 is a clinical trial that has completed, run by Grace Medical. The registered enrollment target is 25 participants.
The verdict
NCT02918942 has completed, sponsored by Grace Medical.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.
Interventions
- DEVICE Tympanoseal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2016-10-04 |
| Est. Completion | 2021-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02918942
The ClinicalTrials.gov registry entry for NCT02918942 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Grace Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tympanoseal is the first listed.
NCT02918942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02918942 about?
NCT02918942 is a clinical study titled "Tympanoseal (Tympanic Membrane Device) Clinical Study". The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or tra...
What is the current status of trial NCT02918942?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2016-10-04. Estimated completion is 2021-09-30.
What interventions are being tested in trial NCT02918942?
The interventions under investigation include: Tympanoseal (DEVICE).
Who is sponsoring clinical trial NCT02918942?
This trial is sponsored by Grace Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.